Miroslav Gasparek

Miroslav Gasparek is the CEO and Co-Founder of Sensible Biotechnologies, a company focused on developing a platform for high-quality mRNA design and manufacturing to address supply chain bottlenecks in biomanufacturing. He is also a co-founder of Nucleate UK, supporting emerging biotech entrepreneurs. Gasparek frequently shares insights on mRNA therapeutics, biomanufacturing, and biosecurity, often referencing scientific papers and industry developments. His content spans topics like mRNA applications in metabolic diseases, cancer vaccines, and autoimmune therapies, as well as discussions on European biotech resilience and strategic infrastructure. He actively engages with the biotech community through speaking engagements, panel discussions, and collaborations with academic and industry leaders.